SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
4.880
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
4.910
+0.030 (0.61%)
Pre-market: Apr 29, 2026, 6:00 AM EDT
SLS Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 876 | 537 | 73 | 34 | 49 | 88 | |
| Market Cap Growth | 769.41% | 633.64% | 115.38% | -30.05% | -44.69% | 59.80% | |
| Enterprise Value | 806 | 493 | 53 | 31 | 28 | 62 | |
| Last Close Price | 4.88 | 3.77 | 1.04 | 1.06 | 2.36 | 5.53 | |
| PS Ratio | - | - | - | - | 48.59 | 11.56 | |
| PB Ratio | 10.54 | 7.58 | 7.73 | -4.26 | 10.02 | 4.32 | |
| P/TBV Ratio | 12.71 | 7.79 | 9.69 | - | 16.54 | 4.77 | |
| EV/Sales Ratio | - | - | - | - | 28.28 | 8.21 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.11 | -0.11 | 0.20 | 0.04 | |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -1.36 | 0.20 | -3.33 | -1.01 | |
| Net Debt / FCF Ratio | 2.49 | 2.49 | 0.36 | 0.05 | 0.68 | 0.79 | |
| Asset Turnover | - | - | - | - | 0.04 | 0.21 | |
| Quick Ratio | 10.23 | 10.23 | 1.46 | 0.18 | 1.10 | 4.29 | |
| Current Ratio | 10.72 | 10.72 | 1.72 | 0.23 | 1.14 | 4.63 | |
| Return on Equity (ROE) | -66.88% | -66.88% | -4147.88% | - | -327.81% | -85.70% | |
| Return on Assets (ROA) | -34.74% | -34.74% | -153.57% | -174.27% | -84.58% | -33.87% | |
| Return on Capital Employed (ROCE) | -38.10% | -38.10% | -317.60% | 503.80% | -588.60% | -92.00% | |
| Earnings Yield | -3.07% | -5.00% | -42.19% | -109.87% | -85.00% | -23.56% | |
| FCF Yield | -3.24% | -5.29% | -48.37% | -92.42% | -49.00% | -29.62% | |
| Buyback Yield / Dilution | -78.18% | -78.18% | -120.33% | -43.21% | -25.29% | -94.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.